Alnylam Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	2,248	1,828	1,037	844.29	492.85	Upgrade
Revenue Growth (YoY)	22.97%	76.23%	22.88%	71.31%	124.28%	Upgrade
Cost of Revenue	323.37	310.41	168.82	140.14	78.05	Upgrade
Gross Profit	1,925	1,518	868.6	704.14	414.8	Upgrade
Selling, General & Admin	975.53	795.65	770.66	620.64	588.42	Upgrade
Research & Development	1,126	1,004	883.02	792.16	654.82	Upgrade
Operating Expenses	2,102	1,800	1,654	1,413	1,243	Upgrade
Operating Income	-176.89	-282.18	-785.07	-708.65	-828.44	Upgrade
Interest Expense	-141.86	-121.22	-155.97	-143.02	-84.5	Upgrade
Interest & Investment Income	121.99	95.56	24.81	1.58	11.81	Upgrade
Other Non Operating Income (Expenses)	-177.6	-108.74	-100.86	-57.75	-8.52	Upgrade
EBT Excluding Unusual Items	-374.35	-416.57	-1,017	-907.84	-909.64	Upgrade
Gain (Loss) on Sale of Investments	-3.02	-16.94	-33.31	55.7	54.04	Upgrade
Other Unusual Items	-	-	-76.59	-	-	Upgrade
Pretax Income	-377.38	-433.52	-1,127	-852.14	-855.6	Upgrade
Income Tax Expense	-99.22	6.73	4.16	0.68	2.68	Upgrade
Net Income	-278.16	-440.24	-1,131	-852.82	-858.28	Upgrade
Net Income to Common	-278.16	-440.24	-1,131	-852.82	-858.28	Upgrade
Shares Outstanding (Basic)	128	125	122	118	115	Upgrade
Shares Outstanding (Diluted)	128	125	122	118	115	Upgrade
Shares Change (YoY)	2.20%	2.64%	2.73%	3.01%	5.24%	Upgrade
EPS (Basic)	-2.18	-3.52	-9.30	-7.20	-7.46	Upgrade
EPS (Diluted)	-2.18	-3.52	-9.30	-7.20	-7.46	Upgrade
Free Cash Flow	-42.59	41.95	-613.33	-718.07	-685.32	Upgrade
Free Cash Flow Per Share	-0.33	0.34	-5.04	-6.06	-5.96	Upgrade
Gross Margin	85.62%	83.02%	83.73%	83.40%	84.16%	Upgrade
Operating Margin	-7.87%	-15.43%	-75.68%	-83.94%	-168.09%	Upgrade
Profit Margin	-12.37%	-24.08%	-109.04%	-101.01%	-174.14%	Upgrade
Free Cash Flow Margin	-1.89%	2.29%	-59.12%	-85.05%	-139.05%	Upgrade
EBITDA	-120.22	-228.12	-740.6	-661.09	-793.67	Upgrade
EBITDA Margin	-5.35%	-12.48%	-71.39%	-78.30%	-161.03%	Upgrade
D&A For EBITDA	56.67	54.05	44.47	47.57	34.77	Upgrade
EBIT	-176.89	-282.18	-785.07	-708.65	-828.44	Upgrade
EBIT Margin	-7.87%	-15.43%	-75.67%	-83.94%	-168.09%	Upgrade
Revenue as Reported	2,248	1,828	1,037	844.29	492.85	Upgrade
Advertising Expenses	29.7	12.4	11.7	-	-	Upgrade

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q